Month: <span>April 2020</span>

Home / 2020 / April
Nutrient deficiency in tumor cells attracts cells that suppress the immune system
Post

Nutrient deficiency in tumor cells attracts cells that suppress the immune system

by IDIBELL-Bellvitge Biomedical Research Institute Some solid tumors have a very high growth rate, which often leads to a lack of vascularization due to the impossibility to develop, at the same time, the blood vessels that accompany and nourish it. The team of Dr. Cristina Muñoz Pinedo, from the Bellvitge Biomedical Research Institute (IDIBELL) and...

CRISPR helps identify potential Alzheimer’s-related protein
Post

CRISPR helps identify potential Alzheimer’s-related protein

by University of Tokyo Experts at the University of Tokyo have identified a new protein in the pathway that leads to Alzheimer’s disease. Researchers used the “molecular scissors” of CRISPR/Cas9 to search for new genes related to the neurodegenerative disease. The exact causes of Alzheimer’s disease remain unknown, but one of the most well-supported theories...

New mask material can remove virus-size nanoparticles
Post

New mask material can remove virus-size nanoparticles

Scientists around the world are scrambling to adapt their research to find solutions to the many problems raised by the Covid-19 pandemic sweeping the world, not the least being a face mask shortage. “We have developed and tested a highly breathable nanocellulose material that can remove particles smaller than 100 nanometres, the size of viruses,”...

First official ATS practice guidelines for Sarcoidosis cover diagnosis and detection
Post

First official ATS practice guidelines for Sarcoidosis cover diagnosis and detection

April 20, 2020–New guidance is available for physicians who must go through a number of steps to provide a probable diagnosis of sarcoidosis – an inflammatory disease that affects the lungs, lymph glands, and other organs. The American Thoracic Society has published an official clinical practice guideline in which a panel of experts strongly recommended...

Post

The pandemic is giving people vivid, unusual dreams. Here’s why

SCIENCECORONAVIRUS COVERAGE The pandemic is giving people vivid, unusual dreams. Here’s why. Researchers explain why withdrawal from our usual environments—due to social distancing—has left dreamers with a dearth of “inspiration.” Deirdre Barrett, a professor of psychology at Harvard University who studies dreams, made this photo illustration of a recent COVID-19 dream she had. ARTWORK BY...

Type 2 diabetes: Too much glucagon when α-cells become insulin resistant
Post

Type 2 diabetes: Too much glucagon when α-cells become insulin resistant

by Uppsala University Patients with type 2 diabetes secrete not only too little insulin but also too much glucagon, which contributes to poor blood glucose control. A new study from Uppsala University suggests that this is because the glucagon-secreting α-cells have become resistant to insulin. In healthy individuals, insulin signals the body to absorb glucose,...

Experimental schizophrenia drug delivers promising human trial results
Post

Experimental schizophrenia drug delivers promising human trial results

By : Rich Haridy A newly published article in the New England Journal of Medicine is reporting the successful results of a clinical trial testing an experimental drug designed to treat psychosis in schizophrenia. The drug works unlike any other existing anti-psychotic medication, and without many of their negative side effects. The development of anti-psychotic...